Metabolomics is invaluable in drug development for evaluating the safety and efficacy of new compounds. It allows for the identification of adverse effects at early stages, optimizing dosage regimens, and understanding the pharmacokinetics and pharmacodynamics of drugs. This accelerates the drug development process and reduces the likelihood of late-stage failures.
